tubulin inhibitor

AMRI Signs Exclusive Option to License its Tubulin Inhibitor Program for Cancer
CP Wire
Tue, 04/3/12 - 10:14 am
tubulin inhibitor
AMRI
Genta starts phase-2 trial of oncology product Tesetaxal
Pharmabiz
Sat, 02/27/10 - 01:17 pm
Genta
Tesetaxel
cancer
tubulin inhibitor